| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/06/2011 | WO2011002258A2 Arginine-based amphiphilic peptide micelle |
| 01/06/2011 | WO2011002239A2 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 01/06/2011 | WO2011002161A2 Transdermal composition comprising tolterodine |
| 01/06/2011 | WO2011002034A1 Needle-like material |
| 01/06/2011 | WO2011001951A1 Ophthalmic composition |
| 01/06/2011 | WO2011001869A1 Method for producing nanospheres, nanospheres, external composition for skin containing same, and cosmetic preparation |
| 01/06/2011 | WO2011001780A1 Method for producing liposomes by two-stage emulsification method using outer aqueous phase containing specific dispersing agent, method for producing liposome dispersion or dry powder thereof using the method for producing liposomes, and liposome dispersion or dry powder thereof produced thereby |
| 01/06/2011 | WO2011001634A1 Method for improving bioavailability of latanoprost |
| 01/06/2011 | WO2011001425A1 Local therapeutic release device |
| 01/06/2011 | WO2011001351A1 Stimuli-responsive carriers for mpi-guided drug delivery |
| 01/06/2011 | WO2011001214A1 Surface amorphization of phenprobamate |
| 01/06/2011 | WO2011001202A1 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application |
| 01/06/2011 | WO2011001181A1 Antimicrobial material |
| 01/06/2011 | WO2011001058A1 Coating composition including marked polymers |
| 01/06/2011 | WO2011001039A1 Micronised progesterone pharmaceutical composition and uses thereof |
| 01/06/2011 | WO2011000924A1 Spray-dried amylase, pharmaceutical preparations comprising the same and use |
| 01/06/2011 | WO2011000835A2 Liposomes for pulmonary application |
| 01/06/2011 | WO2011000811A2 Organic compounds |
| 01/06/2011 | WO2011000581A2 Raloxifene composition |
| 01/06/2011 | WO2011000518A1 Pharmaceutical composition comprising desloratadine |
| 01/06/2011 | WO2011000218A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders |
| 01/06/2011 | WO2011000210A1 Composition of permeation enhancer and use thereof in transdermal drug delivery system |
| 01/06/2011 | WO2011000208A1 Pharmaceutical composition containing dimethicone/ simethicone |
| 01/06/2011 | WO2011000150A1 A medicinal composition for the treatment of bronchitis and preparation thereof |
| 01/06/2011 | WO2011000149A1 Pharmaceutical composition containing ephedrae for treating bronchitis and preparation method therefor |
| 01/06/2011 | WO2011000126A1 Pharmaceutical composition of liposoluble drugs, preparation method and use thereof |
| 01/06/2011 | WO2011000122A1 Formulation based on the synthesis of microspheres made from cross-linked natural gelatine, used as a carrier for strains of probiotic lactobacillus spp. for treating skin wounds and/or lesions |
| 01/06/2011 | WO2011000108A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | WO2011000107A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
| 01/06/2011 | WO2011000106A1 Improved cationic lipids and methods for the delivery of therapeutic agents |
| 01/06/2011 | WO2011000063A1 Aqueous solution of multicomponent inclusion compounds comprising gentamicin and iron il lactate in cy clodextrins, process for the manufacture thereof, use, method of the immunization and good health of domestic animals, kit, and pharmaceutical composition. |
| 01/06/2011 | WO2010132730A3 Hyaluronic acid (ha) injection vehicle |
| 01/06/2011 | WO2010127345A3 Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs |
| 01/06/2011 | WO2010114405A3 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same |
| 01/06/2011 | WO2010104819A3 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery |
| 01/06/2011 | WO2010102196A3 Controlled-release ophthalmic vehicles |
| 01/06/2011 | WO2010102192A3 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/06/2011 | WO2010099292A3 Biodegradable drug or other active delivery system |
| 01/06/2011 | WO2010098627A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010098625A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010089361A3 Process for the preparation of a pharmaceutical composition comprising ezetimibe |
| 01/06/2011 | WO2010089104A3 Resveratrol compositions |
| 01/06/2011 | WO2010075266A3 Intranasal desmopressin administration |
| 01/06/2011 | WO2010072621A3 Process for the preparation of a peptide powder form |
| 01/06/2011 | WO2010070618A3 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
| 01/06/2011 | WO2010054495A3 Non-aqueous colloidal formulation |
| 01/06/2011 | WO2009135593A3 Solid pharmaceutical formulation with delayed release |
| 01/06/2011 | US20110004304 Culturing retinal cells and tissues |
| 01/06/2011 | US20110004218 Process for the preparation of NACRE mechano-structured by mechanosynthesis, mechano-structured NACRE thus obtained and uses thereof |
| 01/06/2011 | US20110004196 Sinus delivery of sustained release therapeutics |
| 01/06/2011 | US20110004195 Sinus delivery of sustained release therapeutics |
| 01/06/2011 | US20110004193 Sinus delivery of sustained release therapeutics |
| 01/06/2011 | US20110004169 Preparation and Use of Sleeve and Micro-Encapsulated Topical Analgesic Patch For Treating Pain |
| 01/06/2011 | US20110004150 Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat |
| 01/06/2011 | US20110003783 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 01/06/2011 | US20110003770 Method and pharmaceutical to treat spinal discs |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110003152 Microcapsules, their use and processes for their manufacture |
| 01/06/2011 | US20110003007 Microparticle and pharmaceutical composition thereof |
| 01/06/2011 | US20110003006 Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics |
| 01/06/2011 | US20110003005 Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| 01/06/2011 | US20110003004 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces |
| 01/06/2011 | US20110003003 Magnetic cells for localizing delivery and tissue repair |
| 01/06/2011 | US20110003002 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 01/06/2011 | US20110003001 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
| 01/06/2011 | US20110003000 Transvaginal Delivery of Drugs |
| 01/06/2011 | US20110002999 Biopolymer System for Tissue Sealing |
| 01/06/2011 | US20110002998 Process for the production of insecticide-modified bead material composed of expandable polystyrene and insecticide-modified moldings obtainable therefrom |
| 01/06/2011 | US20110002997 Photoinitiated tissue filler |
| 01/06/2011 | US20110002996 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue |
| 01/06/2011 | US20110002995 Pharmaceutical composition for the treatment and prevention of cardiac disease |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002993 Film coated tablets containing drospirenone as active agent and a method for the preparation thereof |
| 01/06/2011 | US20110002992 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 01/06/2011 | US20110002991 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof |
| 01/06/2011 | US20110002990 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 01/06/2011 | US20110002989 Methods, dosage forms and kits for administering ziprasidone without food |
| 01/06/2011 | US20110002988 Orally rapidly disintegrating tablet comprising imidafenacin |
| 01/06/2011 | US20110002987 Nicorandil Carriers with Enhanced Stability |
| 01/06/2011 | US20110002986 Stable Shellac Enteric Coating Formulation for Nutraceutical and Pharmaceutical Dosage Forms |
| 01/06/2011 | US20110002985 Abuse resistant drugs, method of use and method of making |
| 01/06/2011 | US20110002984 Formulations comprising exine shells |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002982 Lipid carrier compositions with enhanced blood stability |
| 01/06/2011 | US20110002981 MCPIP Protection Against Cardiac Dysfunction |
| 01/06/2011 | US20110002980 Vaccines using nucleic acid-lipid complexes |
| 01/06/2011 | US20110002979 Styrene maleic anhydride based formulation for male contraception and prostate cancer |
| 01/06/2011 | US20110002978 Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
| 01/06/2011 | US20110002977 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 01/06/2011 | US20110002975 Preoperative treatment of post operative pain |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002973 Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
| 01/06/2011 | US20110002972 Neuroendocrine factors for treatment of degenerative diseases |
| 01/06/2011 | US20110002971 Ceria for use as an antimicrobial barrier and disinfectant in a wound dressing |
| 01/06/2011 | US20110002970 Process for the preparation of nano zinc oxide particles |
| 01/06/2011 | US20110002969 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 01/06/2011 | US20110002968 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition |
| 01/06/2011 | US20110002967 Methods of Transdermally Administering an Indole Serotonin Receptor Agonist and Transdermal Compositions for Use in the Same |
| 01/06/2011 | US20110002966 Vaginal Suppository System and Method |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |